Pedro Delgado is a Psychiatry physician. OpenAlex indexes 515 publications with 6,529 citations (h-index 39); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7703 Floyd Curl Dr
Mail Code 7792
San Antonio, TX 782293901
Telephone
210-567-5391Registry record last updated 8 Jul 2007.
Clinical trials
- Interindividual Postexercise Hypotension Response in Morbid Obesity
Sponsor: Universidad Nacional Andres Bello
- Repetitive Transcranial Magnetic Stimulation as Treatment for Acute Suicidality in Adult Patients
Sponsor: University of Arkansas
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Atypical Antipsychotic31.1%Clozapine37%Quetiapine Fumarate34%Aripiprazole29%Part D<11 patientsSSRI23.6%Escitalopram Oxalate49%Trazodone Hcl26%Citalopram Hbr25%Part D<11 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2007–2013 per NIH RePORTER. The latest:
- Bupropion for Depression in ESRD Patients on Hemodialysis
University of Texas Hlth Science Center
FY2013$107,157R21DK097470 - TRYPTOPHAN DEPLETION: A PHENOTYPIC MARKER FOR DEPRESSION
University of Texas Hlth Science Center
FY2008$1,360M01RR001346 - TRYPTOPHAN DEPLETION: A PHENOTYPIC MARKER FOR DEPRESSION
University of Texas Hlth Science Center
FY2007$11,636M01RR001346
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Examination of pain threshold and neuropeptides in patients with acute suicide risk
Progress in Neuro-Psychopharmacology and Biological Psychiatry
2019 - Using acoustic perception to water sounds in the planning of urban gardens
Building and Environment
2019 - Differential Processing of Physical and Psychological Pain during Acute Suicidality
Psychotherapy and Psychosomatics
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”